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Autophagy and senescence in cancer-associated
fibroblasts metabolically supports tumor
growth and metastasis, via glycolysis
and ketone production
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Senescent fibroblasts are known to promote tumor growth. However, the exact mechanism remains largely unknown.
An important clue comes from recent studies linking autophagy with the onset of senescence. Thus, autophagy and
senescence may be part of the same physiological process, known as the autophagy-senescence transition (AST). To test
this hypothesis, human fibroblasts immortalized with telomerase (hTERT-BJ1) were stably transfected with autophagy
genes (BNIP3, CTSB or ATG16L1). Their overexpression was sufficient to induce a constitutive autophagic phenotype,
with features of mitophagy, mitochondrial dysfunction and a shift toward aerobic glycolysis, resulting in L-lactate and
ketone body production. Autophagic fibroblasts also showed features of senescence, with increased p21(WAF1/CIP1), a
CDK inhibitor, cellular hypertrophy and increased β-galactosidase activity. Thus, we genetically validated the existence
of the autophagy-senescence transition. Importantly, autophagic-senescent fibroblasts promoted tumor growth and
metastasis, when co-injected with human breast cancer cells, independently of angiogenesis. Autophagic-senescent
fibroblasts stimulated mitochondrial metabolism in adjacent cancer cells, when the two cell types were co-cultured,
as visualized by MitoTracker staining. In particular, autophagic ATG16L1 fibroblasts, which produced large amounts of
ketone bodies (3-hydroxy-butyrate), had the strongest effects and promoted metastasis by up to 11-fold. Conversely,
expression of ATG16L1 in epithelial cancer cells inhibited tumor growth, indicating that the effects of autophagy are
compartment-specific. Thus, autophagic-senescent fibroblasts metabolically promote tumor growth and metastasis,
by paracrine production of high-energy mitochondrial fuels. Our current studies provide genetic support for the
importance of “two-compartment tumor metabolism” in driving tumor growth and metastasis via a simple energy
transfer mechanism. Finally, β-galactosidase, a known lysosomal enzyme and biomarker of senescence, was localized to
the tumor stroma in human breast cancer tissues, providing in vivo support for our hypothesis. Bioinformatic analysis of
genome-wide transcriptional profiles from tumor stroma, isolated from human breast cancers, also validated the onset of
an autophagy-senescence transition. Taken together, these studies establish a new functional link between host aging,
autophagy, the tumor microenvironment and cancer metabolism.

Introduction
We previously proposed a new paradigm to explain the role
of autophagy in cancer metabolism.1,2 In this model, tumor
cells secrete hydrogen peroxide, which induces oxidative stress
in adjacent cancer-associated fibroblasts.3,4 Oxidative stress,
in turn, drives the onset of autophagy in cancer-associated

fibroblasts, resulting in mitophagy, mitochondrial dysfunction
and a shift toward aerobic glycolysis.5,6 Autophagy and mitochondrial dysfunction induces a catabolic state in cancer-associated fibroblasts, resulting in the production of high-energy
mitochondrial fuels (such as L-lactate, ketone bodies, glutamine and free fatty acids).7 These mitochondrial fuels are then
transferred to epithelial cancer cells to satisfy their high-energy
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for a “lethal tumor microenvironment”.19 Thus, loss
of stromal Cav-1 reflects its autophagic digestion
by lysosomes, providing a sensitive biomarker for
autophagy in the tumor stroma.5,6,19,23
Our current studies also provide new links
between autophagy and senescence in cancer pathogenesis. For example, it is now well-accepted that
senescent fibroblasts promote tumor growth,24,25 but
the mechanism(s) underlying this phenomenon,26
and their physiological relevance, has remained
elusive.
Autophagy and senescence may be part of the
same biological phenomenon.27,28 In support of
this notion, many of the same stimuli that induce
Figure 1. Fibroblasts overexpressing BNIP3 show a loss of Cav-1 expression, with
autophagy (such as hydrogen peroxide and oxidative
constitutive activation of the autophagic program. BNIP3 was stably overexpressed
stress) also induce senescence,29,30 and myofibroblast
in hTERT fibroblasts via transduction with lenti-viral vectors. Lv-represents fibroblasts
differentation.31 This has implications for undertransduced with the vector-alone control, namely Lv-105 (puro). (A) Note that BNIP3
standing the metabolic importance of cancer-associoverexpression in fibroblasts is sufficient to cause a dramatic reduction in caveolin-1
ated myofibroblasts in tumor growth.
(Cav-1) protein expression, seen by immunoblot analysis. (B) Similarly, BNIP3 overexpression drives the upregulation of LC3-I and -II and cathepsin B, under basal cell
Interestingly, senescent fibroblasts show a proculture conditions. (C) Overnight starvation drives even stronger expression of BNIP3,
gressive increase in lysosomal mass32-34 and a shift
as well as Beclin1 and ATG16L1, which are other key markers of autophagy. Thus, BNIP3
toward aerobic glycolysis.35,36 Thus, this senescence
overexpression in fibroblasts is indeed sufficient to drive a loss of Cav-1 expression via
phenotype may be secondary to the induction of
the activation on an autophagic program. In all three panels, immunoblotting with
autophagy and mitophagy, resulting in mitochonβ-actin is shown as a control for equal protein loading.
drial dysfunction. In further support of this notion,
β-galactosidase, an enzyme marker which is curdemands, driving anabolic tumor growth.8 To take advantage of rently used as the gold standard for measuring the induction of
this increased fuel supply, cancer cells amplify their capacity for senescence, is a known lysosomal enzyme.37 Other recent funcOXPHOS and oxidative mitochondrial metabolism.9,10 Thus, tional studies also directly show that autophagic cells may be
cancer cells and the tumor stroma are metabolically coupled, more sensitive to the induction of senescence.38-44
resulting in a form of “parasitic” cancer metabolism.7 We have
We suggest here that this process could be termed the
termed this new paradigm (1) the “autophagic tumor stroma “autophagy-senescence transition (AST)”, to better reflect that
model of cancer”11-13 or more recently, (2) “two-compartment these two seemingly separate biological phenomena, may be part
tumor metabolism”.14
of a continuum.
This model has important clinical relevance, since protein
In further support of this notion, here we demonstrate that
biomarkers for autophagy and oxidative stress in the tumor genetically engineered autophagic fibroblasts, with tumor- and
stroma effectively predict early tumor recurrence, metastasis, metastasis-promoting activity, also show many characteristics
drug-resistance and poor overall survival in human breast cancer of senescence. Specifically, these autophagic-catabolic fibropatients.15-20 Similar results were also obtained with prostate can- blasts show increased expression of a CDK inhibitor [namely
cer21 and melanoma patients,22 linking “two-compartment tumor p21(WAF1/CIP1)], cellular hypertrophy (increased protein mass
metabolism” with metastasis.
per cell) and elevated levels of β-galactosidase. Similarly, p21
Here, we set out to stringently test the “autophagic tumor has been implicated in driving myofibroblast differentiation in
stroma model of cancer”. We designed a functional genetic cancer-associated fibroblasts45 as well as in the induction of both
approach to validate the role of stromal autophagy in promot- autophagy and senescence.46
ing tumor growth and metastasis. For this purpose, we created a
In summary, stromal autophagy and senescence, which
genetically tractable model using hTERT-immortalized human reflects catabolism in the tumor microenvironment, may metafibroblasts and MDA-MB-231 human breast cancer cells. This bolically promote the anabolic growth of cancer cells. Thus, new
compartment-specific approach allowed us to genetically modify approaches to target the autophagy-senescence transition could
the capacity for either stromal fibroblasts or epithelial cancer cells have important implications for preventing tumor growth and
to undergo autophagy and mitophagy. More specifically, we show metastasis.
that genetically engineered autophagic fibroblasts promote tumor
Since senescence is thought to reflect biological aging, our
growth and metastasis, while constitutive activation of autophagy studies on autophagy-induced senescence may also explain why
in cancer cells effectively reduces tumor growth.
cancer incidence dramatically increases with advanced chronoImportantly, these constitutively autophagic fibroblasts show a logical age, by providing a “fertile soil” or metabolically permisloss of Cav-1 protein expression, consistent with previous studies sive catabolic microenvironment, to support the anabolic growth
showing that a loss of stromal Cav-1 is a prognostic biomarker of “needy” cancer cells.14
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Figure 2. Fibroblasts overexpressing BNIP3 promote tumor growth
without a measurable increase in angiogenesis. To assess the functional
in vivo effects of BNIP3 overexpression in fibroblasts, we employed a
mouse xenograft model. Briefly, MDA-MB-231 breast cancer cells were
co-injected with BNIP3 fibroblasts or vector-alone control fibroblasts,
into the flanks of nude mice. n = 10 per experimental group. Lv-105
represents fibroblasts transduced with the vector-alone control, namely
Lv-105 (puro). (A) Note that at 4 weeks post-injection, BNIP3 fibroblasts
promoted an ~2.1-fold increase in tumor growth. (B) However, no
significant differences in tumor neo-vascularization were observed.
Thus, autophagic BNIP3 fibroblasts are sufficient to drive tumor growth,
without increased angiogenesis.

Results
Fibroblasts overexpressing BNIP3 show a loss of Cav-1 expression with constitutive activation of the autophagic program.
BNIP3 and BNIP3L are two members of the BH3-only subfamily of Bcl-2 family proteins; these proteins form stable homodimeric complexes that localize to the outer membrane of the
mitochondria after cellular stress. This promotes either apoptosis
or the induction of autophagy and/or mitophagy.50
To evaluate the role of BNIP3 and stromal autophagy in tumor
development, BNIP3 was stably overexpressed in hTERT fibroblasts. Figure 1A shows that BNIP3 overexpression in fibroblasts
is sufficient to cause a marked reduction in caveolin-1 (Cav-1)
protein expression. Importantly, loss of stromal Cav-1 expression
predicts early tumor recurrence, metastasis, drug-resistance and
poor overall clinical outcome in human breast cancer patients.16-20
Previous studies have shown that Cav-1 loss is mediated via
lysosomal degradation, during autophagy.5,6,51 Consistent with
this observation, Figure 1B and C show that BNIP3 overexpression drives the upregulation of LC3-I and -II and cathepsin B
(key markers of autophagy and lysosomes) under basal cell culture
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Figure 3. BNIP3L and Beclin1 overexpression in fibroblasts drives a loss
of Cav-1 expression and promotes tumor growth. To investigate the involvement of stromal BNIP3L and Beclin1 in tumor formation, we stably
overexpressed both genes in hTERT fibroblasts. Lv represents fibroblasts transduced with the vector-alone control, namely Lv-105 (puro).
(A) Note that BNIP3L and Beclin1 overexpression in fibroblasts is sufficient to induce a loss of Cav-1 expression, as observed by immunoblot
analysis. Blotting with β-actin is shown as a control for equal protein
loading. (B) BNIP3-, Beclin1- or control fibroblasts were co-injected with
MDA-MB-231 epithelial breast cancer cells, into the flanks of nude mice.
At 4 weeks post-injection, the mice were sacrificed, and the tumors
were collected. n = 10 per experimental group. For both BNIP3L- and
Beclin1 fibroblasts, a significant increase in tumor growth was observed.
Thus, overexpression of both autophagic genes (BNIP3L and Beclin1) is
sufficient to drive tumor growth.

conditions. Furthermore, overnight starvation drives even stronger expression of BNIP3 as well as Beclin1 and ATG16L1, which
are other key markers of autophagy. Thus, BNIP3 overexpression
in fibroblasts is indeed sufficient to drive a loss of Cav-1 expression via the activation on an autophagic program.
In support of our current findings, previous studies have demonstrated that ectopic expression of BNIP3 is sufficient to trigger
autophagy and mitophagy.52
Fibroblasts overexpressing BNIP3 enhance tumor growth
without a measurable increase in angiogenesis. To assess the
functional in vivo effects of BNIP3 overexpression in fibroblasts,
we next employed a mouse xenograft model. MDA-MB-231
breast cancer cells were co-injected with BNIP3 fibroblasts or
vector-alone control fibroblasts into the flanks of athymic nude
mice. Figure 2A shows that at 4 weeks post-injection, BNIP3
fibroblasts promoted an ~2.1-fold increase in tumor growth,
as compared with vector-alone control fibroblasts. However,
Figure 2B shows no differences in tumor neo-vascularization.
Therefore, we conclude that autophagic BNIP3 fibroblasts are
sufficient to promote tumor growth without increased angiogenesis, further validating a crucial role for autophagic stroma in
tumor development.
BNIP3L and Beclin1 overexpression in fibroblasts drives a
loss of Cav-1 expression, and promotes tumor growth. As mentioned above, BNIP3L and BNIP3 are members of the Bcl-2
protein family. BNIP3L and BNIP3 are sufficient to initiate the
autophagic process, even in the absence of nutrient and oxygen
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To investigate if stromal cathepsin B
expression plays a significant functional
role in breast cancer pathogenesis, we
next overexpressed the CTSB gene in
fibroblasts, via lenti-viral transduction.
Note that both the CTSB-precursor and
activated-cleaved form were observed by
immunoblot analysis, in stably transfected hTERT fibroblasts (Fig. 4A).
We also evaluated CTSB expression
after nutrient starvation, a strong natural inducer of autophagy. Figure 4B
shows that CTSB continued to accumulate during starvation, consistent
with its stabilization within lysosomes
during autophagy. Thus, we next evaluated Cav-1 expression after overnight
starvation. As expected, we detected a
strong reduction in Cav-1 protein levels
Figure 4. Fibroblasts overexpressing Cathepsin B (CTSB) show a loss of Cav-1 expression, with con(Fig. 4C), again validating the connecstitutive activation of the autophagic program. (A) To investigate if stromal cathepsin B expression
tion between autophagy induction and
plays a significant functional role in breast cancer pathogenesis, we overexpressed the CTSB gene
loss of Cav-1 protein expression.
in fibroblasts, via lenti-viral transduction. Note that both the CTSB-precursor and activated-cleaved
Immunoblot analysis of CTSB fibroform were observed by immunoblot analysis, in stably transfected hTERT fibroblasts. (B) Cathepsin B
blasts demonstrated that cathepsin B
expression was also evaluated after 12 h and 16 h of starvation (in Hepes-buffered HBSS). Note that
CTSB continued to accumulate during starvation, consistent with its stabilization within lysosomes,
overexpression is sufficient to drive
during autophagy. (C) We also evaluated Cav-1 expression after overnight starvation. As expected,
the induction of autophagy. Indeed,
we detected a strong reduction in Cav-1 protein levels, validating the connection between auFigure 4D shows that cathepsin B
tophagy and loss of Cav-1 protein expression. (D) Immunoblot analysis of CTSB fibroblasts demonoverexpression strongly induces several
strated that cathepsin B overexpression is sufficient to drive the induction of autophagy. Note that
autophagy/mitophagy markers (BNIP3,
cathepsin B overexpression strongly induces several autophagy/mitophagy markers (BNIP3, Lamp1,
Beclin1 and ATG16L1). In all panels, β-actin expression was assessed as a control for equal protein
Lamp1, Beclin1 and ATG16L1).
loading. Lv-represents fibroblasts transduced with the vector-alone control, namely Lv-105 (puro).
Finally, the in vivo functional effects
of stromal CTSB were evaluated using a
xenograft model. Briefly, MDA-MB-231
deprivation.53 Like BNIP3, the mechanism proposed for BNIP3L cells were co-injected with CTSB fibroblasts or vector-alone coninvolves the ability of its BH3-domain to displace Beclin1 from trol fibroblasts into the flanks of nude mice. Figure 5A shows
the Bcl-2- or Bcl-X L-Beclin1 complexes. Beclin1 is then capable that CTSB fibroblasts promoted a significant ~2.1-fold increase
of triggering autophagy, since it is a key regulatory protein in in tumor growth as compared with control fibroblasts. However,
phagophore formation.53
quantitation of neo-vascularization, via immunostaining with
To investigate the involvement of stromal BNIP3L and CD31, did not show any significant increases in tumor angiogenBeclin1 in tumor formation, we stably overexpressed both genes esis (Fig. 5B). Thus, autophagy in the tumor stroma can promote
in hTERT fibroblasts. Figure 3A shows that BNIP3L and Beclin1 tumor growth independently of angiogenesis.
overexpression in fibroblasts is sufficient to induce a loss of Cav-1
Fibroblasts overexpressing ATG16L1 show constitutive actiexpression, as predicted.
vation of the autophagic program and enhanced tumor growth.
In vivo studies were also performed to evaluate if BNIP3L and/ ATG16L1 is a key molecular component of a large protein comor Beclin1 overexpression affects tumor growth. BNIP3, Beclin1 plex essential for autophagy.55 It specifically functions as a clathor control fibroblasts were co-injected with MDA-MB-231 epi- rin adaptor protein during autophagy, thereby facilitating the
thelial breast cancer cells into the flanks of nude mice. At 4 weeks recruitment of plasma membrane, driving autophagosome forpost-injection, the mice were sacrificed, and the tumors were col- mation via endocytosis.56,57
To assess the functional role of stromal ATG16L1 in breast
lected. Figure 3B shows a significant increase in tumor growth of
1.5- and 1.4-fold for BNIP3L and Beclin1, respectively.
cancer development, we stably overexpressed ATG16L1 in
Fibroblasts overexpressing cathepsin B (CTSB) show a loss of hTERT-fibroblasts (Fig. 6A). We also analyzed the induction
Cav-1 expression, with constitutive activation of the autophagic of a panel of autophagy and mitophagy markers. Figure 6B
program, and enhanced tumor growth. Cathepsin B is a cysteine and C show that ATG16L1 overexpression induces the upregulaprotease involved in autophagy that is located primarily within tion of Beclin1 and Lamp1, under basal cell culture conditions.
bona fide lysosomes and lysosome-like organelles, where it func- Similarly, increases in cathepsin B and LC3 were also observed
tions in the degradation and/or processing of lysosomal proteins.54 after overnight starvation.
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In vivo, ATG16L1-fibrolasts promoted tumor growth, resulting in an ~1.6-fold increase in tumor volume relative to control
fibroblasts (Fig. 7A). Again, the increases observed in tumor
growth were independent of tumor angiogenesis (Fig. 7B), as we
previously observed for BNIP3 and CTSB.
BNIP3-, CTSB- and ATG16L1-expressing fibroblasts all
show mitochondrial dysfunction with increased production of
L-lactate or ketone bodies. Autophagy is a process that induces
the degradation of several organelles, including mitochondria.58
Therefore, we evaluated the functional consequences of autophagic genes expression on mitochondrial activity in fibroblasts.
First, we determined the levels of mitochondrial enzymes
associated with the respiratory chain. Figure 8A shows a strong
reduction in key components of complex I, III and IV for all
the genes examined. Furthermore, in CTSB fibroblasts there is a
downregulation of the expression of complex II. These data were
also corroborated by performing MitoTracker staining, which
allows the vital visualization of healthy functional mitochondria. Note that all three types of autophagic fibroblasts (BNIP3,
CTSB and ATG16L1) show dramatic reductions in MitoTracker
staining, indicative of a loss of mitochondrial membrane potential (Fig. 8B).
Loss of functional mitochondria is associated with key changes
in cell metabolism, leading to the accumulation of L-lactate and/
or ketone bodies as end products in the tissue culture media.
Figure 9A shows that BNIP3- and CTSB fibroblasts both
increase L-lactate production, between 25%-to-37%. However,
ATG16L1 fibroblasts did not show any increase in L-lactate
accumulation.
Mitochondrial dysfunction can also activate ketone body
production, resulting in the accumulation of 3-hydroxy-butyrate. Interestingly, only ATG16L1 fibroblasts showed increases
in ketone production, resulting in an up to 2.3-fold accumulation of 3-hydroxy-butyrate (Fig. 9B and C). Thus, BNIP3 and
CTSB fibroblasts produce L-lactate, while ATG16L1 fibroblasts
produce ketone bodies, as a consequence of autophagy induction
and resulting mitochondrial dysfunction.
Since both L-lactate and 3-hydroxy-butyrate are key substrates
for mitochondrial oxidative metabolism, autophagic fibroblasts
would be predicted to promote the mitochondrial activity of
adjacent cancer cells in a paracrine fashion. To test this hypothesis directly, autophagic fibroblasts were co-cultured with MDAMB-231-GFP cells, and mitochondrial activity was visualized by
MitoTracker staining (Fig. 9D).
As predicted, all three fibroblast cell lines stably expressing
autophagy inducers (BNIP3, CTSB and ATG16L1) increased the
MitoTracker staining in adjacent MDA-MB-231 cells during coculture. This is consistent with the notion that autophagic fibroblasts may provide mitochondrial substrates, such as L-lactate
and ketone bodies, for the anabolic growth of cancer cells.
Autophagic fibroblasts promote experimental metastasis and lung colonization. Next, we investigated the ability of
autophagic fibroblasts to increase the metastatic potential of epithelial breast cancer cells. For this purpose, we used an experimental metastasis approach, which measures lung colonization
as an output. Briefly, MDA-MB-231 cells were co-injected with
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Figure 5. Fibroblasts overexpressing Cathepsin B (CTSB) drive enhanced tumor growth without a measurable increase in angiogenesis.
(A) The in vivo functional effects of stromal CTSB were evaluated
using a xenograft model. MDA-MB-231 cells were co-injected with
CTSB fibroblasts or vector-alone control fibroblasts into the flanks of
nude mice. Note that CTSB fibroblasts promoted a significant ~2.1-fold
increase in tumor growth, as compared with control fibroblasts. n = 10
per experimental group. Lv-105 represents fibroblasts transduced with
the vector-alone control, namely Lv-105 (puro). (B) Quantitation of neovascularization, via immunostaining with CD31, did not show any significant increases in tumor angiogenesis. Thus, autophagy in the tumor
stroma can promote tumor growth independently of angiogenesis.

fibroblasts into the tail vein of nude mice. Importantly, the lung
colonization assay showed that all three autophagic fibroblast cell
lines (BNIP3, CTSB and ATG16L1) enhanced the metastatic
capacity of MDA-MB-231 cells as compared with vector-alone
control fibroblasts (Fig. 10A). For example, BNIP3 fibroblasts
and CTSB fibroblasts increased metastasis by ~2.5-fold and
~7-fold, respectively. Interestingly, ATG16L1 fibroblasts showed
the largest capacity for increasing metastasis, driving an ~11-fold
increase. ATG16L1 fibroblasts also showed increases in myofibroblast markers, such as calponin and vimentin, indicating that
autophagy may be also sufficient to promote myofibroblast differentiation (Fig. 10B). Myofibroblasts may play a crucial role in
metastasis.59
Consistent with our current findings, a previous study on
human oral cancers showed that increased stromal expression of
ATG16L1 was associated with both lympho-vascular invasion
and lymph-node metastasis.60 However, the authors did not provide any mechanistic insights into the prognostic value of stromal
ATG16L1 and its association with metastasis.
Autophagic fibroblasts show the induction of p21(WAF1/
CIP1), a CDK inhibitor, and characteristics of senescence:
Cell hypertrophy and β-galactosidase activity. Autophagy has
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Figure 6. Fibroblasts overexpressing ATG16L1 show constitutive activation of the autophagic program. (A) ATG16L1 functions as a clathrin
adaptor protein during autophagy, facilitating the recruitment of plasma membrane, by driving autophagosome formation via endocytosis.
To assess the functional role of stromal ATG16L1 in breast cancer development, we stably overexpressed ATG16L1 in hTERT fibroblasts. (B) Note
that ATG16L1 overexpression induces the upregulation of Beclin1 and
Lamp1, under basal cell culture conditions. (C) Similarly, increases in
cathepsin B and LC3 were also observed after overnight starvation (in
Hepes-buffered HBSS). In all three panels, β-actin expression was assessed as a control for equal protein loading. Lv represents fibroblasts
transduced with the vector-alone control, namely Lv-105 (puro).

Figure 7. Fibroblasts overexpressing ATG16L1 drive enhanced tumor
growth, without a measurable increase in angiogenesis. (A) In vivo,
ATG16L1-fibrolasts also promoted tumor growth, resulting in an
~1.6‑fold increase in tumor volume, relative to control fibroblasts.
n = 10 per experimental group. (B) Increases observed in tumor growth
were independent of tumor angiogenesis, as we previously observed
for BNIP3, and CTSB. Lv-105 represents fibroblasts transduced with the
vector-alone control, namely Lv-105 (puro).

also been linked to the induction of cellular senescence.27,61 In
fact, autophagy and senescence may be viewed as a continuum
of the same biological process. To begin to assess the induction
of a senescence phenotype, we first examined the expression of
CDKI’s (cyclin-dependent kinase inhibitors) and cyclin D1 in all
three autophagic fibroblast cell lines. BNIP3 fibroblasts showed
an induction of p21(WAF1/CIP1) and p16(Ink4a), without any
changes in p19(ARF). Conversely, CTSB- and ATG16L1 fibroblasts showed an induction of p21 and p19, with reductions
in p16. Thus, the most consistent change observed across all
three autophagic fibroblast cell lines was the induction of p21
(Fig. 11A).
Senescent cells also appear flatter and/or hypertrophic, as
protein synthesis may continue without cell division. Indeed, we
noted that BNIP3, CTSB and ATG16L1 fibroblasts all appeared
more hypertrophic, as seen by light microscopy 72 h after cell
plating (Fig. 11B). A more quantitative estimation of cell hypertrophy was achieved by measuring the total amount of protein
per cell (Fig. 12A). Previously, studies have demonstrated that an
increase in cell protein content is related to the induction of cell
cycle arrest and senescence.47 Importantly, BNIP3 and ATG16L1
fibroblasts both showed significant cell hypertrophy (between
30%-to-32%), using this approach, while CTSB fibroblasts also
demonstrated a trend toward cell hypertrophy. Increased protein
mass per cell (hypertrophy) may simply reflect a compensatory

response to constitutive protein degradation (via autophagy),62,63
resulting in increased protein synthesis to avoid cell death.47
Finally, the induction of β-galactosidase activity is currently
the gold standard for measuring the onset of senescence. Thus,
we quantitatively measured the β-galactosidase activity of the
autophagic fibroblast cell lines by FACS analysis. Figure 12B
directly shows that all three autophagic fibroblast cell lines
showed an increase in β-galactosidase activity, as reflected by an
increase in (1) the % of β-Gal-positive cells (up to nearly 3-fold)
and (2) β-Gal mean intensity (up to ~2.25-fold). Similar results
were also obtained with more conventional β-Gal-staining methods, such as in BNIP3 overexpressing fibroblasts (Fig. 12C).
β-galactosidase is predominantly expressed in the tumor
stroma of human breast cancer patients. We next investigated
the possible compartmentalization of β-galactosidase in a panel
of human breast cancer samples, largely derived from patients
with a loss of stromal Cav-1 expression. Interestingly, our results
directly show that, using specific antibodies directed against
β-galactosidase, it is largely confined to the tumor stroma
(Fig. 13). Thus, expression of β-galactosidase in vivo may be
a stromal phenomenon, reflecting the onset of autophagy and
senescence in the tumor stromal compartment. Further studies
are warranted to assess the prognostic value of β-galactosidase as
a new stromal biomarker for predicting clinical outcome of breast
cancer patients.
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ATG16L1 expression in human breast cancer cells
drives autophagy and reduces tumor growth. To understand the compartment-specific role of autophagy in tumor
growth, we also stably overexpressed ATG16L1 in human
breast cancer cells. ATG16L1 overexpression in MDA-MB
231 cells by itself is indeed sufficient to drive autophagy and
mitophagy under baseline cell culture conditions, as evidenced by the loss of Cav-1 expression and the upregulation
of BNIP3 (Fig. 14A and B). Similarly, Figure 14A and B
show that MDA-MB 231 cells harboring ATG16L1 display
the upregulation of certain autophagy markers (Beclin1 and
CTSB) after overnight starvation.
Next, we evaluated the expression of key cell cycle regulators: CDK inhibitors and cyclin D1. Figure 14C shows that
ATG16L1 overexpression in MDA-MB-213 cells induces
p21 expression but no significant changes were detected in
p19 and/or Cyclin D1 protein levels.
Finally, we assessed the capacity of autophagic
MDA-MD-231 cells to undergo tumor growth in vivo after
implantation in the flanks of nude mice. Figure 14D shows
that ATG16L1 overexpression caused a near 2-fold reduction in tumor volume. These “tumor suppressor” effects
Figure 8. BNIP3-, CTSB- and ATG16L1-fibroblasts all show mitochondrial
were independent of angiogenesis, since we did not observe
dysfunction: OXPHOS and MitoTracker. (A) We evaluated the functional
any differences in tumor neo-vascularization, as assessed by
consequences of autophagic genes expression on mitochondrial activity in
quantitation of CD31-positive vessels (Fig. 14E).
fibroblasts by determining the levels of mitochondrial enzymes associated
Thus, the effects of autophagy on tumor cell growth are
with the respiratory chain. Note that a strong reduction in key components of
clearly cell type- and compartment-specific and may exert
complex I, III and IV was observed for all the genes examined. Furthermore,
in CTSB fibroblasts, there is a downregulation of the expression of complex II.
opposing effects depending in which cell type the autophaLv-represents fibroblasts transduced with the vector-alone control, namely
gic program is activated.
Lv-105 (puro). (B) Note that all three types of autophagic fibroblasts (BNIP3,
Validation of the autophagy-senescence transition
CTSB and ATG16L1) show dramatic reductions in MitoTracker staining, indica(AST) by analysis of existing transcriptional profiles of
tive of a loss of mitochondrial membrane potential.
laser-captured tumor stroma isolated from human breast
cancer patient materials. Previously, Morag Park and colleagues48 laser-captured the normal stroma from human breast genetically tractable models that we have created to study twotissue (n = 38 patients) and the tumor stroma from human breast compartment tumor metabolism.
cancers (n = 53 patients). Then, they subjected these patient
Similarly, Table 2 shows a list of senescence-associated genes
materials to genome-wide transcriptional profiling. Of the breast that are specifically upregulated in the tumor stroma of pricancer patients analyzed (n = 53), a significant number of the mary human breast cancers, including p21(WAF1/CIP1), p16
patients analyzed underwent tumor recurrence (n = 11) or metas- (INK4A), cyclin D1/B1 and β-galactosidase. Upregulation of
tasis (n = 25).
cyclin D1 and cyclin B1 may represent compensatory responses
We retrieved these stromal transcriptional profiles from exist- to cell cycle arrest. A more complete list of senescence-associated
ing public databases49 and interrogated them for evidence of genes that are upregulated in the tumor stroma is included as
autophagy and/or senescence in the tumor stroma. These results Table S1 (Supplemental Data).
are summarized briefly in Tables 1 and 2. p-values for these
Thus, this data mining exercise provides additional in vivo
associations are as shown. Table 1 includes a list of autophagy- evidence for the existence of the autophagy-senescence transiassociated genes that are selectively upregulated in the tumor tion (AST) in the tumor microenvironment of human breast
stroma (relative to normal stroma). Note that many of these gene cancers.
transcripts are also specifically upregulated in the tumor stroma
of patients that subsequently underwent tumor recurrence and/
Discussion
or metastatsis (relative to breast cancer patients that did not
undergo recurrence or metastasis).
The role of autophagy in tumorigenesis is complex; its action
This genes list also includes many of the same genes that we may be compartment- and cell type-specific.23 Autophagy was
functionally analyzed by recombinant expression in fibroblasts, originally linked to reduced tumor growth when Beclin1, a crusuch as ATG16L1, BNIP3, BNIP3L, Beclin1 and CTSB as well cial autophagy regulator, was first reported to be deleted in many
as hTERT. Importantly, this supporting bioinformatics data pro- epithelial cancers, indicating that autophagy can function as a
vides direct evidence for the physiological relevance of the new tumor suppressor.64 In dramatic support of this simple concept,
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Figure 9. BNIP3-, CTSB- and ATG16L1-fibroblasts all show mitochondrial dysfunction, with increased production of L-lactate or ketone bodies. (A) Loss
of functional mitochondrial causes changes in cell metabolism, leading to the accumulation of L-lactate. Note that BNIP3- and CTSB-fibroblasts both
show significant increases in L-lactate production, between 25-to-37%. However, ATG16L1 fibroblasts did not show any increases in L-lactate accumulation. (B and C) Mitochondrial dysfunction can also activate ketone body production, resulting in the accumulation of 3-hydroxy-butyrate. Note that
only ATG16L1 fibroblasts showed increases in ketone production, resulting in an up to 2.3-fold accumulation of 3-hydroxy-butyrate. The data were
normalized either for cell number or for protein content per well. Thus, BNIP3- and CTSB fibroblasts produce L-lactate, while ATG16L1 fibroblasts produce ketone bodies, as a consequence of autophagy and the resulting mitochondrial dysfunction. (D) Autophagic fibroblasts were co-cultured with
MDA-MB-231-GFP cells, and mitochondrial activity was visualized by MitoTracker staining. Note that all three autophagic fibroblast cell lines (BNIP3,
CTSB and ATG16L1) increased the MitoTracker staining (red, upper panels) in adjacent MDA-MB-231 cells (green, lower panels), during co-culture. This
is consistent with the notion that autophagic fibroblasts provide mitochondrial fuels, such as L-lactate and ketone bodies, for the anabolic growth of
cancer cells.

recombinant expression of Beclin1 in epithelial cancer cells drives
autophagy and effectively suppresses tumorigenesis.65
Similarly, deficiencies in other autophagy regulators have
been linked to a pro-tumorigenic phenotype.66 More specifically,
autophagy-deficient cancer cells show increased DNA damage and genomic instability as well as increased ROS levels and
oxidative stress.67 Several oncogenes have been shown to repress
autophagy in cancer cells, supporting the overall idea that catabolic processes might be suppressed in tumor cells in order to
favor the accumulation of cell biomass.68
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However, just the opposite effects may be occurring in the
tumor stromal microenvironment (Fig. 15). Thus, a catabolic
tumor stroma, driven by autophagy in cancer-associated fibroblasts, could “energize” the anabolic growth of cancer cells by
providing essential nutrients and mitochondrial fuels (L-lactate,
ketones, glutamine and free fatty acids) in a paracrine fashion.2,69
We have previously termed this hypothesis the “autophagic tumor
stroma model of cancer metabolism”.2,7
More specifically, we have demonstrated that oncogeneinduced activation of H2O2 production in cancer cells drives
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Figure 10. Autophagic fibroblasts promote experimental metastasis and lung colonization. (A) MDA-MB-231 cells were co-injected with fibroblasts
into the tail vein of nude mice. Note that all three autophagic fibroblast cell lines (BNIP3, CTSB and ATG16L1) enhanced the metastatic capacity of MDAMB-231 cells, as compared with vector-alone control fibroblasts. BNIP3 fibroblasts and CTSB fibroblasts increased metastasis by ~2.5-fold and ~7-fold,
respectively. Interestingly, ATG16L1 fibroblasts showed the largest capacity for increasing metastasis, driving an ~11-fold increase. (B) ATG16L1 fibroblasts also showed increases in myofibroblast markers, such as calponin and vimentin, indicating that autophagy may be also sufficient to promote
myofibroblast differentiation. β-actin expression was assessed as a control for equal protein loading.

oxidative stress in cancer-associated fibroblasts (CAFs), which
then undergo autophagy and mitophagy.3,4,70 Loss of mitochondrial function increases aerobic glycolysis, driving the production
and release of micro-nutrients, such as L-lactate and ketone bodies into the tumor microenvironment.11,49,71-73
Ketones and L-lactate, in turn, can act by a paracrine mechanism on cancer cells, driving mitochondrial biogenesis and
OXPHOS (oxidative phosphorylation) in tumor cells, generating a positive feed-forward loop to support anabolic tumor
growth.9,10,74-76
Here, we developed a genetically tractable model system to
directly study the compartment-specific role of autophagy in
tumor growth and metastasis. First, we expressed autophagyassociated genes (such as BNIP3, CTSB and ATG16L1) in
hTERT-immortalized fibroblasts to genetically generate constitutively autophagic fibroblasts. Then, we validated that these
genetically modified fibroblasts undergo autophagy, mitophagy,
develop significant mitochondrial dysfunction and metabolically
shift toward glycolysis, with increased L-lactate and ketone body
production. Importantly, these autophagic fibroblasts effectively
promoted tumor growth and metastasis, mimicking the behavior
of cancer-associated fibroblasts.
Interestingly, we demonstrated that overexpression of a single
autophagy gene is sufficient to drive autophagy induction and
promote tumor growth. Our study establishes that autophagy,
by itself, is sufficient to enhance tumor growth, independently of
neo-vascularization. Autophagy action is clearly compartmentspecific, since we also show that autophagy induction in human
breast cancer cells greatly diminishes tumor growth. Thus, the
induction of autophagy in stroma cells releases nutrients into the
tumor microenvironment, which may support cancer cell growth.
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On the other hand, activation of autophagy in cancer cells drives
the consumption of cellular components and effectively reduces
tumor growth in MDA-MB-231 cells harboring ATG16L1.
A loss of stromal Cav-1 expression, specifically in cancerassociated fibroblasts, is a new important prognostic marker
that predicts early tumor recurrence, lymph node metastasis
and tamoxifen resistance, as well as poor clinical outcome in
breast cancer patients.15-20 The proposed mechanism underlying a loss of stromal Cav-1 in cancer-associated fibroblasts is that
Cav-1 undergoes lysosomal degradation, due to the induction of
autophagy, secondary to oxidative stress.5,6,23,51
Our current data mechanistically validated this hypothesis,
as genetic induction of autophagy/mitophagy with numerous
autophagy-associated genes was indeed sufficient to drive a loss
of Cav-1 protein expression in fibroblasts. Thus, the autophagic destruction of Cav-1 is biomarker for poor prognosis, as the
autophagic tumor stroma provides recycled nutrients to fuel anabolic tumor growth.
We also show that autophagy-induced mitochondrial dysfunction drives a shift toward glycolysis in stromal fibroblasts,
with associated increases L-lactate or ketone body production.
Remarkably, autophagic fibroblasts also promoted tumor cell
metastasis, likely via the production of high-energy mitochondrial fuels, such as L-lactate and ketone bodies, which could be
“burned” by OXPHOS in adjacent cancer cells. In this regard,
ketogenic ATG16L1 fibroblasts showed the highest efficiency in
promoting distant metastasis, resulting in an ~11-fold increase in
lung colonization. Consistent with these findings, ketones are a
more powerful mitochondrial fuel as compared with L-lactate.
Ketones can produce more energy than L-lactate, as they require
substantially less oxygen consumption and can be “burned” by
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rates remain high, primarily due to the metastasis of
primary tumors to distant organs, such as the lungs.82
In diabetic patients, it is possible that breast cancer
metastasis may be augmented by metabolic dysfunction, such as a tendency toward ketone body production. Although these data need to be confirmed with
additional studies, they suggest that ketone bodies
could play a crucial role in breast cancer metastasis.
Recently, several studies have linked autophagy with
senescence. For example, ULK-3, a homolog of ATG1,
induces autophagy in fibroblasts, conferring the acquisition of a senescence phenotype.27,61 Another protein
proposed as a link between autophagy and senescence is
cathepsin B. More specifically, CTSB is able to proteolytically cleave SIRT1, allowing for SIRT1 inactivation
and driving the establishment of a senescence phenotype.83 Thus, autophagy and senescence may be viewed
as a continuum or two related phases of the same overall
biological process.
Our current results also directly support a molecular
link between autophagy and senescence in the tumor
stroma. For example, all the autophagic fibroblast
cell lines we examined (overexpressing either BNIP3,
CTSB or ATG16L1) showed key features of a senescence phenotype, such as (1) induction of p21(WAF1/
CIP1), a well-characterized CDK inhibitor, (2) a
change in cell shape, consistent with cellular hypertrophy and (3) the upregulation of β-galactosidase activity. To confirm the clinical relevance of our findings,
we also examined the distribution of β-galactosidase
in human breast cancers by immunohistochemistry,
Figure 11. Autophagic fibroblasts show the induction of p21(WAF1/CIP1), a CDK
using specifc antibody probes. Interestingly, the disinhibitor and morphologic cell hypertrophy. (A) To assess the induction of a senestribution of β-galactosidase (and thus the senescence
cence phenotype, we examined the expression of CDKI’s (cyclin-dependent kinase
phenotype) was largely confined to the tumor stroma
inhibitors) and cyclin D1, in all three autophagic fibroblast cell lines. BNIP3 fibroblasts showed an induction of p21(WAF/CIP1) and p16(Ink4a), without any changes
and absent from epithelial cancer cells. Thus, senesin p19(ARF). Conversely, CTSB- and ATG16L1 fibroblasts showed an induction of
cence may be primarily confined to the tumor stromal
p21 and p19, with reductions in p16. Thus, the most consistent change observed
compartment. Interestingly, β-galactosidase is also a
across all three autophagic fibroblast cell lines was the induction of p21. (B) Seknown lysosomal enzyme and senescent cells show
nescent cells also appear flatter and/or hyper-trophic, as protein synthesis may
an increase in lysosomal mass,32,37 also supporting
continue without cell division. Note that BNIP3-, CTSB- and ATG16L1 fibroblasts all
appear more hyper-trophic (“wider”), as seen by light microscopy 72 h after cell
the general idea that senescence and autophagy are
plating.
two sides of the same coin. Senescent cells also show a
shift toward aerobic glycolysis,35,36 probably secondary
77,78
to the onset of mitophagy.
mitochondria under ischemic and/or hypoxic conditions.
Importantly, Judy Campisi’s group has previously shown that
Thus, there may be a direct connection between ketone body
senescent fibroblasts promote tumor growth.24-26,84 Her laboratory
production/utilization and cancer cell metastasis.
Ketone bodies are a group of organic molecules are produced attributed the growth-promoting activity of senescent fibroblasts
both in the cytosol and in mitochondria, which are always present to the senescence-associated secretory phenotype (SASP), which
at a low level in healthy individuals. However, dietary manipula- results in the secretion of specific growth factors and cytokines,
tions and certain pathological conditions can increase the levels as well as extracellular matrix remodeling.24,25 However, she
of these compounds in vivo. Pathologies leading to abnormal glu- estimated that the SASP accounts for only ~50% of the tumorcose metabolism, such as poorly controlled diabetes mellitus, can promoting activity of senescent fibroblasts.24,25 The other 50%
drive increased ketone body production.79
still remains unaccounted for.24,25 Importantly, many of the same
Epidemiologic studies suggest that people suffering from stimuli that she used to generate senescent fibroblasts, such as
diabetes are at a higher risk of many forms of cancer (including acute exposure to hydrogen peroxide and oxidative stress, are now
breast, colon, pancreas and etc.,) and diabetes is also associated known to be inducers of autophagy, and are also inducers of myowith reduced survival after cancer.80,81 Breast cancer mortality fibroblast differentiation.29-31 Thus, we propose here that the other
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Figure 12. Autophagic fibroblasts show increased protein mass per cell, and the induction of β-galactosidase activity. (A) A quantitative view of cell
hypertrophy was achieved by measuring the total amount of protein per cell. Previously, it was demonstrated that an increase in cell protein content
is related to the induction of senescence. Note that BNIP3- and ATG16L1 fibroblasts both showed significant cell hypertrophy (between 30-to-32%),
using this approach, while CTSB fibroblasts also showed a trend toward cell hypertrophy. (B) β-galactosidase activity is the gold standard for measuring the onset of senescence. Thus, we quantitatively measured β-galactosidase activity by FACS analysis. Note that all three autophagic fibroblast
cell lines showed an increase in β-galactosidase activity, as reflected by an increase in (1) the % of β-Gal-positive cells and (2) β-Gal mean intensity.
(C) Similar results were obtained with more conventional β-Gal-staining methods, such as in BNIP3-overexpressing fibroblasts.

50% of the tumor-promoting activity of senescent fibroblasts may
actually reflect their autophagic/catabolic phenotype, mitochondrial dysfunction and a shift toward aerobic glycolysis, which
results in production of mitochondrial fuels (such as L-lactate,
ketones, glutamine and free-fatty acids). These mitochondrial
fuels can then “feed” the TCA cycle and OXPHOS in adjacent
cancer cells, allowing for the anabolic growth of tumor cells. In
accordance with our new “metabolic” hypothesis, certain subtypes of senescent fibroblasts promote tumor growth but do not
show the senescence-associated secretory phenotype (SASP).26
Thus, inhibition of autophagy and senescence in cancer-associated fibroblasts is now a new attractive metabolic therapeutic
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target for “cutting off the fuel supply” to rapidly proliferating
cancer cells that are energetically dependent on the tumor stroma.
Materials and Methods
Materials. Commercially available antibodies used were as follows: β-actin (Sigma-Aldrich, #A5441); Cav-1 (BD Transduction
Laboratories, #610406); Beclin1 (Novus Biologicals, #NBP100085); BNIP3 (Abcam, #ab10433); Cathepsin B (FL-339)
(Santa Cruz, #sc-13985); Lamp-1 (E-5) (Santa Cruz, #sc-17768);
LC3 (Abcam, ab48395); ATG16L1 (Abgent, #AP1817a); p21
(H-164) (Santa Cruz, #sc-756); p19 (DCS-240) (Santa Cruz,
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Figure 13. β-galactosidase is predominantly expressed in the tumor
stroma of human breast cancer patients. We investigated the compartmentalization of β-galactosidase in a panel of human breast cancer
samples, using specific-antibodies directed against β-galactosidase.
Note that β-galactosidase is largely confined to the tumor stroma. Thus,
expression of β-galactosidase in vivo may be a stromal phenomenon,
reflecting the onset of senescence in the tumor microenvironment.

#sc-53639); p16 (H-156) (Santa Cruz, #sc-759); cyclin D1
(Thermo Scientific, #MS-210); OXPHOS (MitoSciences,
#MS601); Calponin 1/2/3 (FL-297) (Santa Cruz, #sc-28545);
Vimentin (BD Pharmigen, #550513). Lentiviral vectors containing full-length cDNAs encoding various autophagy genes
(BNIP3, BNIP3L, Beclin1, CTSB and ATG16L1) were all
obtained commercially from GeneCopoeia (Rockville, MD).
Cell culture. Immortalized human fibroblasts (hTERT-BJ1
cells) and human breast cancer cells (MDA-MB-231-GFP), were
cultured in DMEM implemented with 10% fetal bovine serum
(FBS) and penicillin (100 units/mL)/streptomycin (100 μg/mL)
(P/S). Hank’s Balanced salt solution (HBSS) supplemented with
40 mM Hepes and 1% P/S was used to initiate cell starvation.
For co-culture studies, hTERT fibroblasts and MDA-MB-231GFP cells were plated onto glass coverslips in 12-well plates in
complete media at a cellular ratio of 5:1. The next day, the media
was switched to DMEM supplemented with 10% NuSerum.
Cells were maintained in co-culture for 3 d.
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Lenti-virus production and cell line derivation. For lentivirus production, 293Ta cells were transfected with different
plasmids, in particular, EX-neg-Lv105 (the empty vector control), EX-T1853-Lv105 (encoding BNIP3), EX-U0307-Lv105
(encoding BNIP3L), EX-M0768-Lv105 (encoding Beclin1),
EX-Z7498-Lv105 (encoding Beclin1), EX-5654-Lv105 (encoding Cathepsin B), and EX-H2109-Lv105 (encoding ATG16L1).
All plasmids also contained a puromycin resistance marker. The
resulting lenti-viruses were then used to infect hTERT fibroblasts or MDA-MB-231-GFP cells to obtain stable cell lines
overexpressing the target gene of interest.
Immunoblot analysis. Immunoblotting was performed on
samples obtained through OG buffer extraction. For this purpose, cells were scraped in OG lyses buffer (10 mM Tris, pH
7.5, 150 mM NaCl, 1% Triton X-100 and 60 mM n-octyl-glucoside) supplemented with a protease inhibitor cocktail (Roche
Diagnostics) and a phosphatase inhibitor cocktail (Sigma). The
samples were rotated for 40 min, then centrifuged for 10 min at
13,000x g at 4°C. Finally, supernatants were collected. To determine the expression of cell cycle-related proteins, the cells were
scraped into RIPA buffer (50 mM Tris pH 7.5, 150 mM NaCl,
1% Nonidet P-40, 0.5% deoxycholate, 0.1% SDS, plus protease inhibitor and phosphatase inhibitor cocktails) and sonicated
for 20 sec, then the samples were centrifuge 13,000x g for 10
min at 4°C, and the supernatants were collected. The protein
concentrations were determined using the BCA protein assay kit
(Thermo scientific, #23225). Protein lysates were then separated
by SDS-PAGE (using a 10-to-15% acrylamide gel) and transferred to nitrocellulose membranes. To detect expression of the
protein of interest, specific primary antibodies and peroxidaseconjugated secondary antibodies were used. Bound antibodies
were revealed using enhanced chemiluminescence (ECL) substrates (Thermo Scientific).
L-lactate assays. L-lactate levels were assessed according to the
manufacturer’s instructions, using the EnzyChromTM L-Lactate
Assay Kit (cat #ECLC-100, BioAssay Systems). For this purpose,
cells were seeded in 12-well plates in complete media. The next
day, the media was switched to DMEM containing 2% FBS.
After 48 h, the media was collected and the concentration of
L-lactate was measured. Results were normalized for total cell
number.
Mitochondrial vital staining. Cells were seeded onto coverslips in 12-well plates in DMEM containing 10% FBS. After
24 h, the media was change to DMEM supplemented with
10% Nu-serum and 1% P/S. After 48 h, the mitochondria were
labeled by incubating cells with a pre-warmed (37°C) staining
solution containing the MitoTracker Red probe (25 nM for 12
min at 37°C). Then, the cells were washed with PBS, fixed in 2%
PFA and observed under a fluorescence microscope.
Ketone body production. Cells were seeded in 12-well plates
in DMEM supplemented with 10% FBS. The next day, the
media was switched to DMEM without red-phenol, containing 2% FBS. After 48 h, the media was collected, and the ketoacid concentration was measured according the manufacturer’s
instructions using the β-Hydroxy-butyrate (β-HB) Assay Kit
(Biovision, #K632). Results were normalized for either total
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Table 1. Increased expression of autophagy markers and telomerase in the tumor stroma of human breast cancers
Gene stroma

Description

Tumor stroma

Recurrence stroma

Atg16l1

autophagy-related 16-like 1 (yeast)

3.75E-15

1.64E-04

Atg9b

ATG9 autophagy related 9 homolog B (S. cerevisiae)

1.97E-20

1.58E-03

Atg7

autophagy-related 7 (yeast)

7.64E-14

Atg4b

autophagy-related 4B (yeast)

3.49E-05

Atg4a

autophagy-related 4A (yeast)

6.21E-03

Atg3

autophagy-related 3 (yeast)

1.01E-02

Bnip3

BCL2/adenovirus E1B interacting protein 3

Bnip3l

BCL2/adenovirus E1B interacting protein 3-like

2.85E-08

Becn1

beclin 1, autophagy related

7.50E-05

Ctsb

cathepsin B

4.11E-36

Ctsz

cathepsin Z

5.62E-24

Ctsk

cathepsin K

3.28E-20

Ctso

cathepsin O

1.49E-19

Ctse

cathepsin E

1.66E-19

Ctss

cathepsin S

3.70E-18

Ctsw

cathepsin W

1.94E-15

Metastasis stroma

2.75E-02
3.08E-03
8.08E-03

3.27E-02

1.39E-02

3.78E-03

Ctsf

cathepsin F

7.03E-14

Ctsh

cathepsin H

7.21E-12

Ctsg

cathepsin G

1.32E-11

4.03E-04

Tert

telomerase reverse transcriptase

1.34E-11

1.23E-02

Tep1

telomerase associated protein 1

2.21E-07

5.05E-05

Rtel1

regulator of telomere elongation helicase 1

6.03E-06

Terf1

telomeric repeat binding factor 1

Terf2

telomeric repeat binding factor 2

2.17E-02

4.49E-02
3.56E-08

1.63E-02

Data Mining from the Morag Park Data Set: Finak et al. Nature Medicine 2008; 14:518–27. Certain key molecules are highlighted in BOLD, which we
recombinantly overexpressed in human fibroblasts. p-values are as shown.

cell number or total cellular protein per well, depending on the
experiment.
β-galactosidase flow-cytometry assay. Approximately
400,000 cells were seeded per well in 6-well plates in DMEM
with 10% FBS and 1% P/S. The next day, the media was changed
to DMEM with 10% Nu-serum. Cells were then incubated for
48 h at 37°C with 5% CO2, under normal conditions. Then,
the cells were trypsinized, centrifuged and counted to obtain 106
cells. Afterwards, cells were treated according the manufacturer’s
instructions, using the FluoReporter lacZ Flow Cytometry Kit
(Molecular probes, #F-1930). Assay results were evaluated by
flow-cytometry analysis (FACS).
β-galactosidase staining assay. β-galactosidase activity was
also detected by using a Senescence β-Galactosidase Staining
Kit (Cell Signaling, #9860). For this purpose, cells were seeded
into 6-well plates in complete media. After 24 h, the media was
changed to DMEM supplemented with 10% Nu-serum. After
48 h, the cells were fixed and incubated overnight at 37°C in
a dry incubator without CO2, with the β-galactosidase staining
solution. Afterwards, cells were observed under the microscope.
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Cellular hypertrophy assay. Approximately 100,000 cells were
seeded per well in 12-well plates in DMEM containing 10% FBS.
The next day, the media was switched to DMEM, supplemented
with 10% Nu-serum. After 24 h, cells were counted and protein
lysates were prepared with OG buffer. Protein quantification was
performed using the BCA protein assay kit (Thermo scientific,
#23225). The values were obtained were expressed as a ratio
between the total amount of protein per well and the total number of cells per well (protein/cell number). An increased protein/
cell number ratio would be indicative of cellular hypertrophy.47
Animal studies. To evaluate the in vivo tumor promoting
effects of autophagy-related genes, flank injections were performed on athymic NCr nude mice (NCRNU; Taconic Farms;
at 6–8 weeks of age). Experiments were performed according
to the National Institutes of Health (NIH) guidelines, with the
consensus of the Institutional Animal Care and Use Committee
(IACUC) of Thomas Jefferson University. MDA-MB-231-GFP
cells (alone or plus hTERT fibroblasts) were injected into the
flanks of nude mice. More specifically, MDA-MB-231-GFP cancer cells (1 million cells) plus hTERT-BJ1 fibroblasts (300,000
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Figure 14. ATG16L1 expression in human breast cancer cells drives autophagy and reduces tumor growth. (A and B) To understand the compartmentspecific role of autophagy in tumor growth, we also stably overexpressed ATG16L1 in human breast cancer cells. ATG16L1 overexpression in MDA-MB
231 cells by itself is indeed sufficient to drive autophagy and mitophagy under baseline cell culture conditions, as evidenced by the loss of Cav-1
expression and the upregulation of BNIP3 (B). Similarly, MDA-MB 231 cells harboring ATG16L1 display the upregulation of certain autophagy markers
(Beclin1 and CTSB), after overnight starvation (A). (C) Note that ATG16L1 overexpression in MDA-MB-213 cells induces p21 expression, but no significant
changes were detected in p19 and/or Cyclin D1 protein levels. (D) We also assessed the capacity of autophagic MDA-MD-231 cells to undergo tumor
growth in vivo, after implantation in the flanks of nude mice. Note that ATG16L1 overexpression caused a near 2-fold reduction in tumor volume.
(E) However, we did not observe any differences in tumor neo-vascularization, as assessed by quantitation of CD31-positive vessels.
Table 2. Increased expression of CDK inhibitors and beta-gal (senescence markers) in the tumor stroma of human breast cancers
Gene stroma

Description

Tumor stroma

Cdkn1a

cyclin-dependent kinase inhibitor 1A (p21, WAF/CIP1)

3.73E-19

Ciz1

CDKN1A interacting zinc finger protein 1

2.13E-02

Cdkn1b

cyclin-dependent kinase inhibitor 1B (p27, Kip1)

Recurrence stroma

Metastasis stroma

4.59E-03
4.82E-02

Cdkn2a

cyclin-dependent kinase inhibitor 2A (p16, INK4A)

5.71E-29

Cdkn2b

cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)

4.47E-07

Cdkn2c

cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)

1.04E-05

Cdkn3

cyclin-dependent kinase inhibitor 3

9.38E-03
4.12E-02

Ccnb1

cyclin B1

1.53E-04

8.59E-03

Ccnd1

cyclin D1

1.42E-14

3.67E-02

Glb1

galactosidase, beta1

1.91E-23

4.21E-02

Data Mining from the Morag Park Data Set: Finak et al. Nature Medicine 2008; 14:518–27. Certain key molecules are highlighted in BOLD, which we monitored in autophagic fibroblasts overexpressing either BNIP3, CTSB or ATG16L1. p-values are as shown.
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cells) were re-suspended in 100 μl of sterile PBS, just prior to coinjection into the flank. After 4 weeks post-injection, the tumors
were collected, and tumor growth was quantitatively measured.
Experimental metastasis assay. To evaluate the functional
effects of autophagic fibroblasts on distant metastasis, a lung
colonization assay was performed. Briefly, MDA-MB-231-GFP
breast cancer cells were co-injected with fibroblasts in the tail
vein of athymic NCr nude mice (NCRNU; Taconic Farms; at
6–8 weeks of age). More specifically, MDA-MB-231-GFP cancer cells (1 million cells) plus hTERT-BJ1 fibroblasts (300,000
cells) were re-suspended in 100 μl of sterile PBS, just prior to coinjection into the tail vein. After 7 weeks post-injection, the lungs
were insuflated with 15% India ink dye, washed in water and
bleached in Fekete’s solution (70% ethanol, 3.7% para-formaldehyde, 0.75 M glacial acetic acid). A low-power stereo-microscope
was then used to determine the number of negatively stained
metastatic colonies per lung lobe.
Quantitation of tumor angiogenesis. 6 μm tumor frozen sections were fixed with 4% paraformaldehyde in PBS for 10 min at
4°C and washed 3x with PBS. A three-step biotin-streptavidinhorseradish peroxidase method was used for antibody detection.
After fixation, the sections were blocked with 10% rabbit serum
and incubated overnight at 4°C with rat monoclonal CD31
antibody (550274, BD Biosciences). The sections were then
incubated with biotinylated rabbit anti-rat IgG (Vector Labs)
and streptavidin-HRP (Dako). Immunoreactivity was revealed
with 3,3'-diaminobenzidine. For quantitation of vessels, CD31positive vessels were counted in 8–10 fields within the central
area of each tumor using a 20x objective lens and an ocular grid
(0.25 mm2 per field). The total numbers of vessel per unit area
was calculated, and the data was represented graphically.
Immunohistochemistry. Formalin-fixed paraffin-embedded
tumor sections were de-paraffinized, rehydrated and washed in
PBS. Antigen retrieval was performed in 10 mM sodium citrate,
pH 6.0 for 10 min using a pressure cooker. After blocking with
3% hydrogen peroxide for 10 min, sections were incubated with
10% goat serum for 1 h. Then, sections were incubated with primary antibodies (anti-β-galactosidase: Abcam, #ab-96239, at
a dilution of 1:1,000) overnight at 4°C. Antibody binding was
detected using a biotinylated secondary (Vector Labs) followed
by strepavidin-HRP (Dako). Immunoreactivity was revealed
using 3,3'-diaminobenzidine. Finally, samples were counterstained with hematoxylin, dehydrated, mounted and observed
under the microscope.
Bioinformatics analysis. The transcriptional profiles of tumor
stroma isolated by laser-capture from human primary breast cancers,48 were retrieved and re-analyzed, essentially as we previously
described.49
Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

Figure 15. Two-compartment tumor metabolism is fueled by the
autophagy-senescence transition (AST). In this model, cancer cells
secrete hydrogen peroxide (H2O2), which induces oxidative stress in
neighboring normal fibroblasts. Oxidative stress in stromal fibroblasts
is then sufficient to confer the cancer-associated fibroblast phenotype,
resulting in autophagy, mitophagy and a shift toward aerobic glycolysis. Autophagy also drives the onset of senescence via the autophagysenescence transition. Autophagic-senescent fibroblasts then produce
high-energy nutrients (L-lactate, ketone bodies, glutamine and free
fatty acids), which “fuel” mitochondrial metabolism (OXPHOS and β-OX;
oxidative phosphorylation and β-oxidation) in adjacent cancer cells,
resulting in the onset of anabolic tumor growth. This simple model
could explain why chronological aging is one of the most significant
risk factors for the development of cancer. AST, autophagy-senescence
transition.
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